Evidence map›Paper›PMID 41081046›Full record

ArticleFrontiers in cell and developmental biology2025

Jia-Qi Wu, Han-Peng Zou, Ruo-Yue Fan, Jing Cai, Ping Wei, Ming-Fang He, Jin Xiang

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jia-Qi WuCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Han-Peng ZouCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Ruo-Yue FanCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Jing CaiCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Ping WeiCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Ming-Fang HeCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Jin XiangDepartment of Science and Technology, The Affiliated Cancer Hospital of Nanjing Medical University and Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Brain metastasis (BM) remains a major challenge in non-small cell lung cancer (NSCLC) treatment, with poorly understood mechanisms. Methods: A zebrafish xenograft model was established using the H1299 cell line to study NSCLC BM. RNA-Seq identified differentially expressed genes (DEGs) in metastasized to brain vs. non-metastasized cells. Clinical relevance of DEGs was validated using The Cancer Genome Atlas (TCGA) and Kaplan-Meier survival analysis. The anti-proliferation, migration, and invasion effects of Results: Through comprehensive RNA-Seq analysis of zebrafish xenograft model, we identified 177 DEGs significantly associated with NSCLC BM. KEGG and GO enrichment identified Conclusion: This study identifies

Indexed as

brain metastasisGNA13NSCLCWnt/β cateninzebrafish

Identifiers

PMID41081046
PMCPMC12511054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.